Nav: Home

Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)

August 28, 2017

Barcelona, Spain - 28 Aug 2017: Education of healthcare providers and patients with atrial fibrillation has led to a 9% absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet.

This corresponds to a more than three-fold increase in anticoagulation use from baseline to one year in the intervention group, compared with the control group. The increased drug use was accompanied by a modest, but notable, reduction in the risk of stroke.

"More than 33 million people worldwide have atrial fibrillation, which is a leading cause of stroke," said principal investigator Prof Christopher Granger, professor of medicine at Duke Clinical Research Institute, Durham, US.

"Only about half of patients with atrial fibrillation take anticoagulant drugs, despite these medications being highly effective in preventing strokes," he continued. "Increasing the use of anticoagulation therapies has the potential to prevent hundreds of thousands of strokes each year."

The IMPACT-AF trial2 assessed whether education of providers and patients with atrial fibrillation, with monitoring and feedback, could increase the use of oral anticoagulation compared to usual care. The trial included 2 281 patients with atrial fibrillation from 48 centres in Argentina, Brazil, China, India and Romania. In each country, centres were randomised in a 1:1 ratio to receive an educational intervention (intervention group) or usual care (control group) for one year.

The educational intervention was customised to each country and explained the benefits of anticoagulant therapies, as well as the risks and costs. Patients were given brochures and shown videos, and then monitored at doctor visits to get their feedback and learn of any problems that kept them from staying on the medication. Physicians received information and reports from the researchers through emails, articles, webinars and podcasts. The primary outcome was the change in the proportion of patients treated with oral anticoagulation at one year.

At one year, the overall use of anticoagulation therapies had risen by 11.7% in the intervention group and 2.6% in the control group (p = 0.0002). When the researchers looked only at patients not treated with any anticoagulation therapy at the start of the study, they found that 48% of those in the intervention group were on an anticoagulant at one year compared to only 18% in the control group (p < 0.0001).

Prof Granger said: "The trial shows that education and monitoring are effective ways to improve adherence to oral anticoagulation medication in patients with atrial fibrillation. If this intervention was broadly applied, which we believe is possible, the public health implications could be substantial."

The researchers also found that during the follow-up, 1.0% of patients in the intervention group had a stroke compared to 2.0% of patients in the control group, corresponding to a 52% reduction (p = 0.04). In fact, the number needed to treat (NNT) was 100 patients exposed to intervention to prevent one stroke event over a one-year period.

"We observed a reduction in strokes in the intervention compared to the control group," said Prof Dragos Vinereanu, professor of cardiology at the University of Medicine and Pharmacy Carol Davila, Bucharest, Romania and the principal investigator for Romania. "Stroke reduction is the ultimate goal, and this finding shows the potential benefit of improving anticoagulation care."

Prof Granger pointed out that a limitation of the cluster randomisation design, in which centres (rather than individual patients) are assigned to the intervention or control arm, was that baseline use of anticoagulants may have been overestimated in the control sites.

He concluded: "Additional studies are needed to better understand why such a large proportion of patients with atrial fibrillation discontinue, or never even start, oral anticoagulation therapy."

European Society of Cardiology

Related Stroke Articles:

Retraining the brain to see after stroke
A new study out today in Neurology, provides the first evidence that rigorous visual training restores rudimentary sight in patients who went partially blind after suffering a stroke, while patients who did not train continued to get progressively worse.
Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.
Imaging stroke risk in 4-D
A new MRI technique developed at Northwestern University detects blood flow velocity to identify who is most at risk for stroke, so they can be treated accordingly.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Pre-stroke risk factors influence long-term future stroke, dementia risk
If you had heart disease risk factors, such as high blood pressure, before your first stoke, your risk of suffering subsequent strokes and dementia long after your initial stroke may be higher.
Intervention methods of stroke need to focus on prevention for blacks to reduce stroke mortality
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
Study shows area undamaged by stroke remains so, regardless of time stroke is left untreated
A study led by Achala Vagal, M.D., associate professor at the University of Cincinnati College of Medicine and a UC Health radiologist, looked at a group of untreated acute stroke patients and found that there was no evidence of time dependence on damage outcomes for the penumbra, or tissue that is at risk of progressing to dead tissue but is still salvageable if blood flow is returned in a stroke, but rather an association with collateral flow -- or rerouting of blood through clear vessels.
Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events.
SAGE launches the European Stroke Journal with the European Stroke Organisation
SAGE, a world leading independent and academic publisher, is delighted to announce the launch of the European Stroke Journal, the flagship journal of the European Stroke Organisation.
The S-stroke or I-stroke?
The year 2016 is an Olympic year. Developments in high-performance swimwear for swimming continue to advance, along with other areas of scientific research.

Related Stroke Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".